Dr. Havard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3838 S 700
Ste 100
Salt Lake City, UT 84106Phone+1 801-269-0231Fax+1 801-262-9494- Is this information wrong?
Education & Training
- University of Utah HealthFellowship, Hematology and Medical Oncology, 2016 - 2019
- University of Virginia Medical CenterResidency, Internal Medicine, 2013 - 2016
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2013
Certifications & Licensure
- UT State Medical License 2016 - 2026
- VA State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy Start of enrollment: 2019 Dec 15
Publications & Presentations
PubMed
- 12 citationsAnti-CD19 Chimeric Antigen Receptor T Cell Therapies: Harnessing the Power of the Immune System to Fight Diffuse Large B Cell Lymphoma.Robert Havard, Deborah M. Stephens> ;Current Hematologic Malignancy Reports. 2018 Dec 1
- 1 citationsIntegrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer.Robert Havard, N. Lynn Henry> ;Future Oncology. 2017 Nov 23
- Early Palliative Care Reduces End‐of‐Life Intensive Care Unit (ICU) Use but Not ICU Course in Patients with Advanced CancerRobert Havard, Andrew M. Romano, Paul W. Read, Kristine E. Gade, Gradon Nielsen> ;The Oncologist. 2017 Feb 22
Hospital Affiliations
- LDS HospitalSalt Lake City, Utah
- Riverton HospitalRiverton, Utah
- Intermountain Medical CenterSalt Lake City, Utah
- Alta View HospitalSandy, Utah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: